I would like to invite you to take part in our research study, which is investigating anxiety and depressive symptoms in the Spanish population during the COVID-19 outbreak.

We have an online questionnaire

That takes about 30 min to complete. We also ask that you please share this with all your networks, friends and family accross Spain. We greatly appreciate your assistance. Below is the invitation email which you could use to forward via email invitation.


Last Publications


libro personas mayores

A Practice Primer

English Version

May 2019


Vol.9 Sistema Dopaminérgico y Trastornos Psiquiátricos

Vol.10 Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

June 2013

ISBN: 978-1-4614-7263-6

Next Course

November, 11th and 12th 2019

XIII Intensive Theoretical-Practical Course of update in Electroconvulsive Therapy

More information

Last Meeting

June, 20th-21th 2014

"Relevance of Staging Psychotic disorders as a Paradigm-shift for understanding disease progression and stage-dependent treatment"

More information


Vol.2 Schizophrenia, Movement Disorders, and Age Related Cognitive Disorders

Vol.2 Schizophrenia, Movement Disorders, and Age Related Cognitive Disorders

June 1994

Editors: Tomás Palomo, Richard J. Beninger, Trevor Archer

Publisher: Editorial Complutense, Donoso Cortés, 65, 28015 MADRID

ISBN: 84-7491-504-X

Pages: 434

More information

Also found within the publications are contributions presented at the meeting held in Madrid in 1992.

Table of contents
  1. Psychotic disorders
    1. Strategies for the Choice of Animal Models in the Evaluation ofAtypical Antipsychotic Drugs .S. Ahlenius
    2. Role of Olfactory Tubercle and Nucleus Accumbens in the effects ofClassical and Atypical Neuroleptics: search for regional specificity.A.R. Cools, E.P.M. Prinssen, B A. Ellenbroek and D J. Heeren
    3. Yawning induced by Low Doses of Apomorphine as a Possible BiologicalMarker for Studying the effects of CNS Active Compounds on theDopamine System .M. Casas, G. Prat, J. Guardia and P. Duro
    4. Remoxipride - Preclinical Predictions and Clinical Outcome .T.Lewander, D.M. Jackson, M. Blomqvist, S. Ogenstad and B. Gustafsson
    5. Potential Mechanisms underlying the Atypical Antipsychotic Profile ofRemoxipride .S.O. Ögren
    6. A Clinician's View of Animal Research in Schizophrenia Studies .T.Palomo
    7. Ondansetron: a double-blind, placebo-controlled study in acuteschizophrenia. .J. Wilson, P.G. Cooksey and S.L. McBain
    8. Clinical Characteristics of Atypical Antipsychotic Drugs .B.Woggon
    9. Sertindole -an Atypical Neuroleptic .C. Sánchez
  2. Movement disorders
    1. Neuroanatomical Consequences of Psychostimulant Drugs: effects afteradult and prenatal exposure .P.M. Groves, D. Jackson, J.C. Linder,M.S. Manley, L.J. Ryan and S.J. Young
    2. The Peculiar Pharmacology of Bromocriptine .D.M. Jackson, J.A.Watson and S.B. Ross
    3. MPTP-induced Behavioural Deficits in Mice: validity and utility of amodel of parkinsonism .A. Fredriksson and T. Archer
    4. Huntington's Disease: behavioral pathology and animal models .D.F.Emerich, T.B. Freeman, D.W. Cahill, C.W. Olanow and P.R. Sanberg
    5. Parkinson's Disease: PET, pharmacokinetics and therapeutic strategies.S.M. Aquilonius
    6. Neurotrophic Factors for the Treatment of Neurological Disorders: themodel of Parkinson's disease .M. Angeles Mena, M. JoséCasajeros and J. Garcia de Yébenes
    7. Rehabilitation of Patients with Parkinson's .A. Portera-Sánchez
  3. Cognitive disorders
    1. Critical Issues in Cognition Enhancing Drug Research .R.Porsolt,S. Roux and A. Lenègre
    2. Dopaminergic-Cholinergic Function in Neo-Striatal Memory Function:role of nigro-striatal terminals .N.M. White, M. Viaud and M.G.Packard
    3. Glutamatergic Receptors, Learning and Dementia: implications for theupdate of screening methods .W. Danysz and W.J. Schmidt
    4. Memory Processing by the Amygdala, Hippocampus and Entorhinal Cortex:role of glutamatergic and GABA-A receptors .I. Izquierdo
    5. Strategies "in Search of the Engram": a half-century later.R.W. Russell
    6. ACTH Neuropeptides and Recovery from Brain Injury .D. de Wied
    7. Effects of ACTH Neuropeptides on Nerve Repair and Neuropathy: animaland human studies .W.H. Gispen, A.C. Kappelle, B. Bravenboer,F.P.T. Hamers and P.M. Edwards
    8. Developing and Regenerating Systems as Models tor Trophic Effects ofACTH Neuropeptides .F.L. Strand, S.E. Alves, F.J. Antonawich, S.J.Lee, T.S. Lee and L.A. Zuccarelli
    9. The ICD-10 Classification of Dementias .J.J. López-Ibor
    10. Clinical Features of Alzheimer's Disease .D.G. Cole and J.H.Growdon

Fundación Cerebro y Mente
c/ General Oraa, 47 - 1º E 28006 Madrid, España
Telf: +34 91 561 1267 Fax: +34 91 564 1817

Resolución mínima: 1024 x 768. Navegadores recomendados: Google Chrome / Firefox 3.5+ / Internet Explorer 9.0+ / Opera 9.0+ / Safari 3.0+